IL17A and cancer: These genes were primarily enriched in pathways related to immune response, inflammation resolution, lysosomal activity, autophagy enhancement, and the mitigation of protease-mediated tissue damage, as well as lipid metabolism, atherosclerosis-related pathways, cancer-related pathways, and the IL-17 and NOD-like receptor pathways (Figures 2C,D).